# Zhejiang POCTech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhejiang-poctech-co

- Industry: Medical Devices & Equipment
- Headquarters: Huzhou, China
- Website: www.poctechcorp.com
- Total disclosed funding: $19M
- Latest round: Series B (Apr 14, 2017)
- Investors on record: 5

## About

Based in Zhejiang, China and established in 2010, Zhejiang POCTech Co.,Ltd. operates as a developer of medical device that monitors glucose levels for diabetic patients. The founder of the company is a Doctor of Bioanalytical Chemistry, Kansas University, USA and Postdoctoral Fellow of Pharmaceutical Analytical Chemistry and Biosensors. He served as as pharmaceutical analysis scientist at Oread Inc, chief sensor scientist at Medtronic, and research and development director at MicroCHIPS. In 2015, The company passed the clinical test of CT-100 continuous glucose monitoring (CGM). The company raised 2 round funding and was acquired by a medical instrument company Jiangsu Yuyue Medical Equipment & Supply for RMB 366 million.

The company provides medical portable monitoring system including CGM devices, handheld blood-gas, electrolyte analyzer, and blood glucose tester. The CT-100 continuous glucose monitoring (CGM) has gained CE certification.

## Funding rounds

- Series B, Apr 14, 2017, $19M — Legend Capital, YuanBio Venture, Tasly Pharmaceutical Co., Ltd., Tonghua Dongbao Pharmaceutical Co., Ltd.
- Series A, Dec 1, 2014 — Legend Capital, LenoMed Medical

## Investors

- Legend Capital — Series A, Series B
- LenoMed Medical — Series A
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series B
- Tasly Pharmaceutical Co., Ltd. — Series B
- Tonghua Dongbao Pharmaceutical Co., Ltd. — Series B